HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Manjusha Gaglani Selected Research

COVID-19 Vaccines

3/2024Risk of COVID-19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric Disorders.
2/2024Longitudinal parental perception of COVID-19 vaccines for children in a multi-site, cohort study.
1/2024Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years.
12/2023Impact of accounting for correlation between COVID-19 and influenza vaccination in a COVID-19 vaccine effectiveness evaluation using a test-negative design.
11/2023Effectiveness of the Original Monovalent Coronavirus Disease 2019 Vaccines in Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Adults With Disabilities: VISION Network, June 2021-September 2022.
8/2023Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023.
1/2023Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network.
1/2023Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods.
1/2023Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022.
1/2023Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report-IVY Network, February 1-August 31, 2022.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Manjusha Gaglani Research Topics

Disease

78COVID-19
04/2024 - 01/2021
75Human Influenza (Influenza)
04/2024 - 02/2014
36Infections
03/2024 - 02/2014
3Cough
01/2023 - 05/2016
3Breakthrough Infections
01/2022 - 01/2021
2Respiratory Insufficiency (Respiratory Failure)
12/2023 - 03/2022
2Critical Illness (Critically Ill)
05/2023 - 01/2023
2Fever (Fevers)
10/2022 - 01/2018
2Disease Progression
10/2022 - 11/2021
2Pneumonia (Pneumonitis)
01/2022 - 01/2018
2Respiratory Tract Infections (Respiratory Tract Infection)
01/2020 - 01/2018
1Mental Disorders (Mental Disorder)
03/2024
1Hypoxia (Hypoxemia)
12/2023
1Renal Insufficiency (Renal Failure)
12/2023
1Vision Disorders (Hemeralopia)
11/2023
1Chills
10/2022
1Hepatitis D
10/2022
1Coinfection
10/2022
1Thrombocytopenia (Thrombopenia)
04/2022
1Thrombosis (Thrombus)
04/2022
1Asymptomatic Infections
08/2021
1Drug-Related Side Effects and Adverse Reactions
12/2020
1Frailty
01/2019
1Pharyngitis (Sore Throat)
01/2018
1Sinusitis
01/2018
1Bronchitis
01/2018
1Herpesviridae Infections (Herpesvirus Infection)
02/2014
1Measles
10/2011
1Mumps
10/2011
1Chickenpox
10/2011
1Rubella (German Measles)
10/2011

Drug/Important Bio-Agent (IBA)

103VaccinesIBA
03/2024 - 10/2011
46Influenza Vaccines (Influenza Vaccine)FDA Link
02/2024 - 02/2014
38mRNA VaccinesIBA
02/2024 - 01/2021
36Messenger RNA (mRNA)IBA
03/2024 - 01/2021
36COVID-19 VaccinesIBA
03/2024 - 04/2021
11BNT162 VaccineIBA
01/2023 - 01/2021
10RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2023 - 02/2014
7N-(2-cyanoethylene)urea (BA 1)IBA
09/2023 - 07/2022
6Antiviral Agents (Antivirals)IBA
03/2022 - 02/2014
5Combined VaccinesIBA
01/2024 - 01/2021
5AntibodiesIBA
12/2023 - 01/2015
52019-nCoV Vaccine mRNA-1273IBA
03/2022 - 01/2021
5Hemagglutinins (Hemagglutinin)IBA
01/2021 - 01/2015
4Neutralizing AntibodiesIBA
09/2023 - 01/2022
4N-methyl-valyl-amiclenomycin (BA 2)IBA
01/2023 - 07/2022
3Proteins (Proteins, Gene)FDA Link
11/2023 - 10/2022
3Anti-Bacterial Agents (Antibiotics)IBA
12/2020 - 09/2014
2Oxygen (Dioxygen)IBA
12/2023 - 10/2023
2Immunoglobulin G (IgG)IBA
11/2023 - 09/2021
2Viral RNAIBA
11/2023 - 01/2021
2AntigensIBA
09/2023 - 01/2023
2Ad26COVS1IBA
10/2022 - 10/2021
2Attenuated VaccinesIBA
01/2021 - 10/2017
2Inactivated VaccinesIBA
01/2021 - 12/2018
2Neuraminidase (Sialidase)IBA
09/2016 - 01/2015
1Respiratory Syncytial Virus VaccinesIBA
04/2024
1perfluorooctane sulfonic acidIBA
12/2023
1perfluorooctanoic acidIBA
12/2023
1perfluoro-n-nonanoic acidIBA
12/2023
1perfluorohexanesulfonic acidIBA
12/2023
1Nucleocapsid ProteinsIBA
11/2023
1RNA (Ribonucleic Acid)IBA
11/2023
1EpitopesIBA
09/2023
1NucleoproteinsIBA
10/2022
1COVID-19 vaccine booster shotIBA
04/2022
1Stored Messenger RNAIBA
01/2022
1Dihydrotachysterol (AT 10)IBA
12/2021
1Nucleic AcidsIBA
11/2021
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2019
1CI 22IBA
01/2019
1Hepatitis A Vaccines (Hepatitis A Vaccine)IBA
10/2011

Therapy/Procedure

21Ambulatory Care (Outpatient Care)
03/2024 - 09/2014
7Artificial Respiration (Mechanical Ventilation)
04/2024 - 11/2021
2Therapeutics
10/2023 - 09/2014
1Noninvasive Ventilation
10/2023
1Cannula
10/2023
1Critical Care (Surgical Intensive Care)
01/2022
1Mechanical Ventilators (Ventilator)
12/2021
1Length of Stay
12/2021